Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients

American Journal of Clinical Nutrition

Volumn 82, Issue 6, 2005, Pages 1235-1243

  Pupim, Lara B ^a   Flakoll, Paul J ^b   Yu, Chang ^a   Ikizler, T Alp ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Exercise; Growth hormone; Hemodialysis; Intradialytic parenteral nutrition; Metabolism

Indexed keywords

GLUCOSE; HUMAN GROWTH HORMONE; LEUCINE; MUSCLE PROTEIN; AMINO ACID; CARBON; PROTEIN; RECOMBINANT PROTEIN;

ADULT; AMINO ACID TRANSPORT; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DRUG EFFECT; ENERGY EXPENDITURE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS PATIENT; HORMONE BLOOD LEVEL; HUMAN; INTRADIALYTIC PARENTERAL NUTRITION; MALE; PROTEIN METABOLISM; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; ENERGY METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; PARENTERAL NUTRITION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SKELETAL MUSCLE; TREATMENT OUTCOME;

ADULT; AMINO ACIDS; CARBON ISOTOPES; CROSS-OVER STUDIES; ENERGY METABOLISM; EXERCISE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MUSCLE, SKELETAL; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PARENTERAL NUTRITION; PROTEINS; RECOMBINANT PROTEINS; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 33644692485     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/82.6.1235     Document Type: Article

References (39)

1. USRDS. The United States Renal Data System. Am J Kidney Dis 2003; 42:1-230.
2. Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic patenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 2002; 110:483-92.
3. Pupim LB, Flakoll PJ, Levenhagen DK, Ikizler TA. Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients. Am J Physiol Endocrinol Metab 2004;286:E589-97.
4. Mehls O, Ritz E, Hunziker EB, Eggli P, Heinrich U, Zapf J. Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 1988;33:45-52.
5. Chan W, Valerie KC, Chan JCM. Expression of insulin-like growth factor-1 in uremic rats: growth hormone resistance and nutritional in-take. Kidney Int 1993;43:790-5.
6. Ikizler TA, Wingard RL, Breyer JA, Schulman G, Parker RA, Hakim RM. Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int 1994;46:1178-83.
7. Ikizler TA, Wingard RL, Flakoll PJ, Schulman G, Parker RA, Hakim RM. Effects of recombinant human growth hormone on plasma and dialysate amino acid profiles in CAPD patients. Kidney Int 1996;50: 229-34.
8. Ziegler TR, Lazarus JM, Young LS, Hakim R, Wilmore DW. Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 1991;2:1130-5.
9. Hansen TB, Gram J, Jensen PB, et al. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Clin Nephrol 2000;53:99-107.
10. Johannsson G, Bengtsson BA, Ahlmen J. Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement. Am J Kidney Dis 1999;33:709-17.
11. Wasserman K. Principles of exercise testing & interpretation: including pathophysiology and clinical applications. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1999.
12. Kopple JD, Foulks CJ, Piraino B, Beto JA, Goldstein J. National Kidney Foundation position paper on proposed health care financing: administration guidelines for reimbursement of enteral and parenteral nutrition. J Renal Nutr 1996;6:45-7.
13. Goldstein DS, Feuerstein G, Izzo JL Jr, Kopin IJ, Keiser HR. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 1981;28:467-75.
14. Morgan CR, Lazarow A. Immunoassay of insulin: two antibody system. Plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 1963;12:115-26.
15. Heinrikson RI, Meredith SC. Amino acid analysis by reverse-phase high pressure liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem 1984;136:65-74.
16. Nissen SL, Van Huysen C, Haymond MW. Measurement of branched-chain α-ketoacids in plasma by high performance liquid chromatography. J Chromatogr 1982;232:170-5.
17. Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Raymond MW. Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem 1984;141:101-9.
18. 13C enrichment of carbon dioxide in breath and blood samples using the Finnigan MAT breath gas analysis system. Biomed Environ Mass Spectrom 1988;15:365-7.
19. Wolfe RR. Radioactive and stable isotope tracers in biomedicine: principles and practice of kinetic analysis. New York, NY: Wiley-Liss, 1992:283-316.
20. Allsop JR, Wolfe RR, Burke JF. Tracer priming the bicarbonate pool. J Appl Physiol 1978;45:137-9.
21. Garlick PJ, McNurlan MA, McHardy KC, et al. Rates of nutrient utilization in man measured by combined respiratory gas analysis and stable isotopic labeling: effect of food intake. Hum Nutr Clin Nutr 1987;41:177-91.
22. Jequier E, Acheson K, Schutz Y. Assessment of energy expenditure and fuel utilization in man. Annu Rev Nutr 1987;7:187-208.
23. Mauras N. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects. J Clin Endocrinol Metab 1995;80:2633-7.
24. Carli F, Webster JD, Halliday D. Growth hormone modulates amino acid oxidation in the surgical patient: leucine kinetics during the fasted and fed state using moderate nitrogenous and caloric diet and recombinant human growth hormone. Metabolism 1997;46:23-8.
25. Pfeifer M, Poredos P, Zizek B. Effect of growth hormone (GH) therapy on endothelial function in GH-deficient adults. J Clin Endocrinol Metab 2000;85:4923.
26. Darmaun D, Hayes V, Schaeffer D, Welch S, Mauras N. Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis. J Clin Endocrinol Metab 2004;89:1146-52.
27. Mauras N, Rini A, Welch S, Sager B, Murphy SP. Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys. Metabolism 2003;52:964-9.
28. Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls O. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 1991;5:539-44.
29. Fouque D, Peng SC, Kopple JD. Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 1995; 47:876-83.
30. Fouque D, Peng SC, Kopple JD. Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients. Kidney Int 1995; 47:869-75.
31. Ding H, Kopple JD, Cohen A, Hirschberg R. Recombinant human insulin-like growth factor-1 accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 1993;91:2281-7.
32. Garibotto G, Barreca A, Russo R, et al. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 1997;99:97-105.
33. Wolfson M, Jones MR, Kopple JD. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 1982;21: 500-6.
34. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994;46:830-7.
35. Davis TA, Bush JA, Vann RC, Suryawan A, Kimball SR, Burrin DG. Somatotropin regulation of protein metabolism in pigs. J Anim Sci 2004;82(E-suppl):E207-13.
36. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80-101.
37. Press M. Growth hormone and metabolism. Diabetes Metab Rev 1988; 4:391-414.
38. Keller U, Gerber PP, Stauffacher W. Stimulatory effect of norepinephrine on ketogenesis in normal and insulin-deficient humans. Am J Physiol 1984;247:E732-9.
39. Kraenzlin ME, Keller U, Keller A, Thelin A, Arnaud MJ, Stauffacher W. Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms. J Clin Invest 1989;84:388-93.